Basics
Description
- Injury to the walls of blood vessels from inflammation:
- Ischemia and necrosis
- Aneurysms and hemorrhage
- Immunopathologic mechanisms:
- Deposition of circulating antigen " “antibody complex and complement fixation
- Cell-mediated hypersensitivity
- Granulomatous tissue reaction from persistent inflammation and formation of epithelioid giant cells
- The vasculitides represent a wide group of disorders:
- Multisystem disease with constitutional symptoms and inflammatory lab indices
- Secondary to another disorder or trigger, or primary if vasculitis is the principal feature and the cause is unknown
- Multiple factors determine presentation:
- The size of the affected blood vessels
- The specific distribution, severity, and duration of the inflammation
- Degree of permeability or occlusion of the affected vessels
- 1 out of 2,000 adults has some form of vasculitis
Etiology
- Classification is evolving and is increasingly based on presence or absence of antineutrophil cytoplasmic antibodies (ANCA).
- Traditional classification is based on vessel size.
- Large vessel vasculitides:
- Temporal (giant cell) arteritis:
- Granulomatous arteritis of the aorta and its major branches often involving the temporal artery
- Patients >50 yr
- Takayasu arteritis:
- Granulomatous inflammation of the aorta and its major branches
- Usually occurs in patients <50 yr
- Medium vessel vasculitides:
- Polyarteritis nodosa (PAN):
- Small- and medium-sized arteritis
- Common distribution includes vessels supplying the muscles, joints, intestines, nerves, kidneys, and skin
- Most common in middle age
- Kawasaki disease (mucocutaneous lymph node syndrome):
- Coronary arteries are often involved and involves large-, medium-, and small-sized arteries
- Usually occurs in children
- Isolated CNS vasculitis
- Small vessel vasculitides:
- Granulomatosis with polyangiitis (Wegener granulomatosis):
- Necrotizing vasculitis affecting small- to medium-sized vessels
- Granulomatous inflammation of the upper and lower respiratory tract and glomerulonephritis
- Microscopic polyangiitis:
- Necrotizing affecting small vessels
- Glomerulonephritis is very common.
- Pulmonary capillaritis often occurs.
- Churg " “Strauss syndrome (allergic granulomatosis):
- Small- and medium-sized arteries
- Mainly lungs, GI, and nerves
- Can also involve heart, skin, and kidney
- Henoch " “Sch ƒ ¶nlein purpura:
- Buerger disease (thromboangiitis obliterans):
- Hypersensitivity vasculitis:
- Recurring inflammation and thrombosis of small and medium arteries and veins of the hands and feet
- Typically between 20 and 40 yr and male
- Secondary vasculitides:
- Bacterial infections:
- Streptococcal, tuberculous, staphylococcal, Lyme disease, leprosy
- Viral infections:
- Hepatitis B or C, CMV, HSV, HIV
- Rickettsial infections
- Drug related
- Connective tissue disease:
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Beh ƒ §et disease
- Malignancy:
- Hairy cell leukemia
- Lymphoma
- Mixed cryoglobulinemia
- Goodpasture syndrome
- Serum sickness
Diagnosis
Signs and Symptoms
- Systemic complaints are common early in the presentation of vasculitis, before vascular-related complications occur:
- Fever, fatigue, weight loss, diffuse aches and pains
- Signs of arterial insufficiency:
- Ischemic pain:
- Angina, abdominal angina, claudication, jaw claudication
- Neurologic ischemia:
- Headache, TIA, stroke, visual and sensorineural hearing loss, hallucinations, neuropathy, vision loss
- Renal ischemia:
- Dermatologic ischemia:
- Classic skin findings include palpable purpura.
- Nodular lesions, ulcers, livedo reticularis, and digital ischemia may also be seen
- Oligoarthritis
- Ocular ischemia:
- Diplopia, retinal hemorrhages, scleritis, and episcleritis
- Respiratory tract:
- Sinusitis, epistaxis, nasal and oral ulcerations, strawberry tongue
- GI ischemia:
- Hematochezia, melena, hematemesis, peritonitis, hepatitis
- Cardiac:
- Coronary artery aneurysms, myocarditis, pericarditis, valvular disease, CHF
History
- Suspect vasculitis with general systems and signs of arterial insufficiency:
- Claudication, angina, abdominal angina, or TIA, in a young patient
- Prolonged systemic illness with multiorgan dysfunction
- History of glomerulonephritis, peripheral neuropathy, or autoimmune disease
- Diagnostic clues to the etiology:
- Age, gender, ethnicity, travel history
- Specific complaints that suggest the size of the involved vessel and organs
- Recent infections
- Connective tissue disorders
- Medications that may cause vasculitis:
- Levsamisole (as a cocaine adulterant), phenytoin, carbamazepine, isoniazid, methimazole, minocycline, penicillamine, propylthiouracil, sulfasalazine
Physical Exam
Classify vasculitis: ‚
- Large arteries:
- Diminished pulses and bruits over several large arteries
- BP discrepancy >10 mm Hg between left and right limbs
- Pulse discrepancy >30 mm Hg between the left and right limbs
- Cool extremities due to claudication and ulceration
- Medium and small arteries:
- Palpable purpura (nodules, ulcers, livedo papules)
- Skin ulcers
- Digital ischemia
Essential Workup
- History and physical exam
- CBC, ESR, CRP, urinalysis, BUN, creatinine
Diagnosis Tests & Interpretation
Lab
- CBC:
- Leukocytosis
- Eosinophilia
- Anemia
- Creatinine
- LFT
- CRP
- ESR
- ANA
- ANCA
- Complement
- CPK
- Urinalysis:
- Proteinuria and hematuria
Imaging
- CXR:
- PAN usually has a nonspecific patchy alveolar infiltration.
- CT scan:
- Sinus CT for suspected granulomatosis with polyangiitis (Wegener)
- CTA:
- Coronary artery aneurysms in Kawasaki
- Echocardiography:
- Coronary artery aneurysms in Kawasaki
- MRI and MRA:
- Positron emission tomography (PET) scan for suspected Takayasu and Kawasaki
- ECG:
- Indications:
- Suspected Takayasu and Kawasaki
- US:
- Temporal artery US for suspected giant cell arteritis
- Use pretest probability in interpretation of results
- Arteriography
Diagnostic Procedures/Surgery
- EKG:
- Pericarditis, conduction disturbances
- Endoscopy, sigmoidoscopy, and colonoscopy for GI tract involvement
- Tissue biopsy
Differential Diagnosis
- Endocarditis
- Adverse drug reaction
- Viral infections (e.g., enterovirus)
- Scarlet fever " ¨
- Staphylococcal scalded skin syndrome " ¨
- Toxic shock syndrome " ¨
- Stevens " “Johnson syndrome
- Rocky Mountain spotted fever " ¨
- Leptospirosis
- Antiphospholipid antibody syndrome
- Disseminated intravascular coagulation
- Cholesterol emboli
- Calciphylaxis
Treatment
Initial Stabilization/Therapy
Stabilization of cerebrovascular complications ‚
Ed Treatment/Procedures
- Treatment for vasculitis is determined by the underlying cause or the specific disease and is best initiated by rheumatology.
- Kawasaki: Aspirin, IVIG
- Giant cell arteritis: Corticosteroids
- PAN: Steroids, cyclophosphamide
- Takayasu arteritis: Corticosteroids, methotrexate, azathioprine, cyclophosphamide
- Wegner granulomatosis: Corticosteroids:
- Cyclophosphamide, azathioprine may be substituted
- Plasma exchange may be helpful in severe disease.
Medication
- Azathioprine: 2 mg/kg/d PO
- Cyclophosphamide:
- IV: 0.5 " “1 mg/m2 body surface area
- PO: 2 mg/kg/d (up to 4 mg/kg) (peds: dose as per consultant)
- IVIG: 1 " “2 g/kg IV
- Methylprednisolone: 0.25 " “1 mg/d IV
- Methotrexate: 7.5 " “15 mg/wk PO
- Prednisolone: 1 mg/kg/d PO
- Prednisone: 40 " “60 mg/d (peds: 1 " “2 mg/kg/d) PO
Follow-Up
Disposition
Admission Criteria
- Patients with evidence of severe disease and end-organ dysfunction should be admitted.
- Consult for procedures to revascularize ischemic organs.
Discharge Criteria
Less-symptomatic patients without evidence of end-organ involvement ‚
Issues for Referral
- Any patient suspected of vasculitis and being managed as an outpatient should be referred as soon as possible to a rheumatologist for the definitive diagnosis and treatment.
- Consult appropriate specialties based on the severity of the end-organ damage.
Followup Recommendations
Stress the need for close follow-up with general symptoms to confirm the diagnosis and initiate therapy that will be life-saving on a long-term basis. ‚
Pearls and Pitfalls
- Drug therapy may be toxic; do not prescribe without specialist consultation.
- Patients may be immunosuppressed and at risk for opportunistic pathogens.
- Do not miss subacute bacterial endocarditis as a mimic of vasculitis.
- Temporal (giant cell) arteritis does not occur before age 50 yr.
- Nodular lesions are the skin changes most likely to yield a diagnosis of vasculitis.
Additional Reading
- Langford ‚ CA. Vasculitis. J Allerg Clin Immunol. 2010;125(2 suppl 2):S216 " “S225.
- Lapraik ‚ C, Watts ‚ R, Bacon ‚ P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford). 2007;46(10):1615 " “1616.
- Mukhtyar ‚ C, Guillevin ‚ L, Cid ‚ MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310 " “317.
- Newburger ‚ JW, Takahashi ‚ M, Gerber ‚ MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708 " “1733.
- Semple ‚ D, Keogh ‚ J, Forni ‚ L, et al. Clinical review: Vasculitis on the intensive care unit-part 1: Diagnosis. Crit Care. 2005;9(1):92 " “97.
- Semple ‚ D, Keogh ‚ J, Forni ‚ L, et al. Clinical review: Vasculitis on the intensive care unit-part 2: Treatment and prognosis. Crit Care. 2005;9(2):193 " “197.
See Also (Topic, Algorithm, Electronic Media Element)
- Erythema Nodosum
- Henoch " “Sch ƒ ¶nlein Purpura
- Hepatitis
- Reiter Syndrome
- Systemic Lupus Erythematosus
Codes
ICD9
- 446.0 Polyarteritis nodosa
- 446.5 Giant cell arteritis
- 447.6 Arteritis, unspecified
- 443.1 Thromboangiitis obliterans [Buergers disease]
ICD10
- I77.6 Arteritis, unspecified
- M30.0 Polyarteritis nodosa
- M31.6 Other giant cell arteritis
- I73.1 Thromboangiitis obliterans [Buergers disease]
- M31.4 Aortic arch syndrome [Takayasu]
SNOMED
- 31996006 Vasculitis (disorder)
- 400130008 Temporal arteritis (disorder)
- 155441006 Polyarteritis nodosa (disorder)
- 52403007 Thromboangiitis obliterans (disorder)
- 11791001 Necrotizing vasculitis (disorder)
- 359789008 Takayasus disease (disorder)
- 70933002 Aortitis (disorder)